Nature of change: Appointment of Senior Management Personnel (SMP)
Name and details: Mr. Indranil Mukherjee appointed as Chief Executive Officer - Asia Pacific and India Business
Effective date: June 1, 2026
Term: Full-Time Employment
Reporting structure: Will report directly to the Managing Director of the Company
Profile and qualifications: Seasoned medical technology executive with over 30 years of broad-based leadership experience spanning critical care, infusion therapy, renal care, surgical instruments, vascular systems, wound care, and implantable devices. Has demonstrated track record as a change agent, scaling up business, leading market expansion, M&A integration, organisational restructuring, and strategy execution.
Career history: Built foundational career at B. Braun, managing Hospital, Outpatient Care, and Aesculap (Vascular) portfolios across India. Transferred to B. Braun's headquarters in Germany as Global Sales Manager in 2010. Served as Regional Head for Hospital Care at Asia Pacific headquarters in Penang, Malaysia. Later served as Managing Director at B. Braun Group in India, delivering turnaround and sustained profitable growth across multiple product lines spanning three manufacturing plants and a team of over 2,000 colleagues. Most recently served as Chief Executive Officer of Translumina Therapeutics, a global cardiovascular implants company with operations in India and Germany.
Education: Graduated in Chemistry from St. Xavier's College, Ranchi; MBA from Bhopal University; SMP from IIM Calcutta; LBTA from INSEAD Singapore.
Regulatory compliance: Appointment categorized as Senior Management Personnel (SMP) under SEBI Listing Regulations. Disclosure made pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
Approval process: Appointment approved by the Board of Directors based on recommendation of Nomination and Remuneration Committee via circular resolutions passed on June 01, 2026.
Any Other Material Information
The disclosure includes complete Annexure-A with all required details as per SEBI Master Circular format
Company Secretary Mr. Avinash Chandra (M. No. A32270) digitally signed and submitted the disclosure on June 01, 2026
The company's registered office is at 232 B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020
